Release Date: 11/08/14 16:58 Summary: Change in substantial holding Lim Price Sensitive: No Download Document 218.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%